Life Sciences & Biomedicine Pharmacology & Pharmacy Psychiatry Psychology Psychology, Biological Psychology, Clinical Science & Technology Social Sciences
Transdermal nicotine patch (TNP) is 1 of the most commonly used smoking cessation treatments; however, the efficacy of TNP by sex is not yet clear. The purpose of the current review was to synthesize how sex has been considered in published clinical trials of TNP for smoking cessation. The specific aims of the study were to examine the inclusion of sex in analyses of cessation outcomes, TNP-related variables (compliance, side effects), and quit-related variables (withdrawal, cravings); to review the consideration of sex-related variables (menstrual cycle phase, pregnancy); and to identify needs for future research. Potential articles published through December 31, 2013 were identified through a MEDLINE search of the terms "clinical trial," "nicotine patch," and "smoking cessation." Forty-two studies used all 3 terms and met the inclusion criteria. Approximately half of the studies reported that they considered sex in smoking cessation outcomes, with 15 studies finding no difference by sex and 7 studies finding better outcomes for men versus women. Only 5 studies reported data on outcomes by sex in their publications. No studies reported analysis of TNP compliance or withdrawal by sex. In the 1 study that examined side effects by sex, more women than men reported discontinuing TNP because of skin irritation. No study examined the association of cessation outcomes with menstrual cycle phase. There is a need to include sex in research on TNP, as well as other pharmacological and behavioral smoking treatments, to clarify the picture of treatment efficacy for women compared with men.
Consideration of Sex in Clinical Trials of Transdermal Nicotine Patch: A Systematic Review
Creators
Andrea H. Weinberger - Yale University
Philip H. Smith - Yale University
Mira Kaufman - John Brown University
Sherry A. McKee - Yale University
Publication Details
Experimental and clinical psychopharmacology, v 22(5), pp 373-383
Publisher
Amer Psychological Assoc
Number of pages
11
Grant note
Grace J. Fippinger Foundation
NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
P50-DA033945 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
State of Connecticut, Department of Mental Health and Addiction Services
Resource Type
Journal article
Language
English
Academic Unit
A.J. Drexel Autism Institute
Web of Science ID
WOS:000348310700001
Scopus ID
2-s2.0-84925746496
Other Identifier
991022030932804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
Collaboration types
Domestic collaboration
Web of Science research areas
Pharmacology & Pharmacy
Psychiatry
Psychology, Biological
Psychology, Clinical
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services